Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients

Overview of attention for article published in Frontiers in immunology, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 34,219 followers.

Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients https://t.co/bHTEuHav5p

18 Feb 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer pat…

29 Jan 2024

Reply Repost Favourite

New Research: Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients: Extensive stage-Small-Cell Lung Cancer (ES-SCLC) is an aggressive cancer with dismal prognosis. The addition of… https://t.co/O6

29 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.